Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.

ClinicalTrials.gov 5 recruiting now small index

Developmental Delay clinical trials

5 of 11 indexed Developmental Delay trials are currently recruiting.

Corpus placement: #1,577 of 28,707 conditions by registered trial count.

11 US clinical trials · 5 currently recruiting · #1,577 of 28,707 conditions by registered trial count

Developmental Delay: 11 US clinical trials tracked, 5 recruiting.

Developmental Delay is the subject of 11 registered US clinical trials on ClinicalTrials.gov, 5 of them currently open to new participants. The most active sponsor is University of Illinois at Chicago, running 2 of these trials.

Enrollment posture brief

Registry condition developmental-delay

OPEN 5 | RECR 45% | LATE 0 | EARLY 0 | RANK #1577 | SPON 2

Nearest open-share peer: Advanced Breast Carcinoma (45% recruiting · 11 trials)

Acute Pancreatitis81.8%Acute Stroke45.5%Developmental Delay (this)45%Acquired Brain Injury36.4%Acute Lung Injury9.1%
Open-enrollment share among volume-matched conditions near Developmental Delay

Developmental Delay lists 5 open slots (45% of 11 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →

Key findings

What ClinicalTrials.gov does not surface for Developmental Delay on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.

  1. Developmental Delay recruits in line with its size-band peers.

    5 of 11 indexed trials (45.5%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.

  2. One sponsor concentrates Developmental Delay research.

    University of Illinois at Chicago accounts for 2 of 11 trials (18.2%). 9 distinct sponsors appear on at least one study for this condition label.

  3. Typical Developmental Delay enrolment sits around 223 participants.

    Median target enrolment is 223 among the 11 trials that report a genuine target (sentinel values excluded). 3 of those (27.3%) plan for fewer than 100 participants.

  4. Developmental Delay splits between interventional and observational designs.

    6 interventional and 5 observational studies make up this index (54.5% interventional). Study type is sponsor-reported on ClinicalTrials.gov.

Open and recent trials

11 total, page 1 of 1

RECRUITING 1,000 participants

Longitudinal Study of Neurogenetic Disorders

Columbia University

NCT03492060

RECRUITING NA 320 participants

School-based Support for Pre-school Aged Children With Developmental Disabilities and Delays

University of Illinois at Chicago

NCT06145659

RECRUITING 200 participants

Mirror Neuron Network Dysfunction as an Early Biomarker of Neurodevelopmental Disorder

Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)

NCT03307317

RECRUITING NA 20 participants

Improving Neurodevelopmental ouTcomes After Prenatal Cannabinoid in uTero Exposure

IDeA States Pediatric Clinical Trials Network

NCT06423664

RECRUITING NA 9 participants

Problem Behavior Assessment and Intervention in IDEA Part C Services

University of Nevada, Las Vegas

NCT06771284

ACTIVE NOT RECRUITING 297 participants

Mitochondrial Dysfunction in Autism Spectrum Disorder

University of Arkansas

NCT02000284

ACTIVE NOT RECRUITING NA 223 participants

Exploratory Trial of a Pediatric Web-Based Care Planning Guide

University of Illinois at Chicago

NCT06458959

COMPLETED NA 360 participants

The CHICA Developmental Screening Study

Indiana University

NCT01351077

COMPLETED 304 participants

Improving Autism Screening With Brain-Related miRNA

Milton S. Hershey Medical Center

NCT02712853

COMPLETED NA 144 participants

Can Novel Telemedicine Tools Reduce Disparities Related to Early Identification of Autism

Vanderbilt University Medical Center

NCT03847337

COMPLETED 96 participants

Pediatric Patients With Metabolic or Other Genetic Disorders

Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)

NCT02769949

Phase Distribution

Phase data not available

Named interventions

Most-linked intervention names on Developmental Delay records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.

Vineland Adaptive Behavior Scale-II Assessment Other
1 trials
CHICA DevScreen Module Other
1 trials
Telehealth-Autism Spectrum Disorder-Pediatrics (ASD-PEDS) Other
1 trials
Telehealth-Screening Tool for Autism in Toddlers (STAT) Other
1 trials
PEM+ Behavioral
1 trials
Function-based assessment and intervention Behavioral
1 trials
Preschool and Me Behavioral
1 trials
Saliva collection Other
1 trials

US sites by state

Facility locations filed on Developmental Delay trials. A trial with sites in several states counts in each.

Tennessee 2 trials
Maryland 2 trials
Illinois 2 trials
Vermont 1 trials
South Dakota 1 trials
Pennsylvania 1 trials
New York 1 trials
Nevada 1 trials

Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.

What to do with this Developmental Delay page

11 registered trials, 5 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Developmental Delay condition card totals 11 registered trials; most-linked intervention Vineland Adaptive Behavior Scale-II Assessment; top US site state Tennessee. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.